Cathay Joins Qiming in Autoimmune Drug Development
09 Dec 2025
US$ 20.00
Cathay Capital has led the series A funding round of Embios that raised an undisclosed amount. Qiming Venture ......
Related Publications
Subscribers’ Weekly for the week ending 12 Dec 2025...
Listen to Subscribers' Weekly 12 Dec 2025...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.